NCT07299162 The Effect of Virtual Reality Therapy on Upper Extremity Functions in Subacute Stroke Patients Receiving Rehabilitation
| NCT ID | NCT07299162 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Physical Medicine Rehabilitation Training and Research Hospital |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 38 participants |
| Start Date | 2025-08-15 |
| Primary Completion | 2026-03-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 38 participants in total. It began in 2025-08-15 with a primary completion date of 2026-03-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke ranks second among the leading causes of death worldwide and third among the causes of disability. In stroke patients, motor impairment typically affects facial movements and the upper and lower extremities unilaterally. Upper extremity involvement, in particular, negatively impacts patients' activities of daily living, such as eating and dressing. Various rehabilitation methods are used to improve the function of the paretic upper extremity in stroke patients. Action Observation Therapy and Virtual Reality are among the rehabilitation approaches currently used to support upper extremity rehabilitation. In our study, patients will be randomly divided into two groups: one group will receive conventional rehabilitation and Action Observation Therapy, while the other group will additionally receive Virtual Reality therapy. This study aims to investigate the contribution of Virtual Reality therapy, when added to conventional rehabilitation and Action Observation Therapy, to the recovery of the paretic upper extremity in patients with subacute stroke.
Eligibility Criteria
Inclusion Criteria: * Patients over the age of 18 * Patients in the subacute phase of stroke (between 6 weeks and 6 months post-stroke) * Patients with a first-ever stroke * Brunnstrom stage 3 or above for both upper extremity and hand * Mini-Mental State Examination (MMSE) score \>=20 No major medical condition that would prevent participation in the treatment Exclusion Criteria: * Presence of pain in the paretic shoulder severe enough to prevent exercise * History of bilateral stroke * Patients with global aphasia and/or cognitive impairment that significantly affects treatment compliance * Patients with severe visual impairment * Presence of unilateral spatial neglect * Inability to maintain sitting balance * Modified Ashworth Scale \> 4 in the hemiplegic arm
Contact & Investigator
Seda Akbayrak, MD
PRINCIPAL INVESTIGATOR
Istanbul Physical Therapy and Rehabilitation Training and Research Hospital
Frequently Asked Questions
Who can join the NCT07299162 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07299162 currently recruiting?
Yes, NCT07299162 is actively recruiting participants. Contact the research team at akbayrakseda@gmail.com for enrollment information.
Where is the NCT07299162 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07299162 clinical trial?
NCT07299162 is sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital. The principal investigator is Seda Akbayrak, MD at Istanbul Physical Therapy and Rehabilitation Training and Research Hospital. The trial plans to enroll 38 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.